PatientsVille.com Logo

PatientsVille

Carteol Side Effects

Common Carteol Side Effects


The most commonly reported Carteol side effects (click to view or check a box to report):

Bradycardia (9)
Muscular Weakness (6)
Peripheral Coldness (6)
Amyotrophy (6)
Systemic Lupus Erythematosus (5)
Atrioventricular Block (5)
Intraocular Pressure Increased (4)
Electrocardiogram Qrs Complex Prolonged (4)
Meningioma (4)
Disorientation (4)
Diarrhoea (4)
Blood Creatinine Increased (4)
Blood Potassium Increased (3)
Arthritis (3)
Dizziness (3)
Eye Pain (3)
Oropharyngeal Blistering (3)
Blood Sodium Decreased (3)
Idiopathic Thrombocytopenic Purpura (3)
Visual Acuity Reduced (3)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Carteol Side Effects Reported to FDA

The following Carteol reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Carteol on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Systemic Lupus Erythematosus, Muscular Weakness, Hyperhidrosis, Cardiac Disorder, Alopecia
This is a report of a 53-year-old female patient (weight: NA) from FR, suffering from the following symptoms/conditions: glaucoma, who was treated with Carteol Lp 2% Collyre A Liberation Prolongee En Recipient Unidose (dosage: NA, start time: 201002), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Systemic Lupus Erythematosus
  • Muscular Weakness
  • Hyperhidrosis
  • Cardiac Disorder
  • Alopecia
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Carteol Lp 2% Collyre A Liberation Prolongee En Recipient Unidose treatment in female patients, resulting in systemic lupus erythematosus side effect.

Hyperkalaemia, Sinus Bradycardia
This report suggests a potential Carteol 1% Collyre Hyperkalaemia, Sinus Bradycardia side effect(s) that can have serious consequences. A 90-year-old female patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: NA and used Carteol 1% Collyre (dosage: NA) starting Aug 27, 2013. Soon after starting Carteol 1% Collyre the patient began experiencing various side effects, including:
  • Hyperkalaemia
  • Sinus Bradycardia
Drugs used concurrently:
  • Cardensiel
  • Keppra
  • Tahor
  • Plavix
  • Azopt Collyre
  • Lumigan
  • Levemir
  • Actrapid
Although Carteol 1% Collyre demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as hyperkalaemia, may still occur.

Alopecia Totalis, Anti-thyroid Antibody, Chest Pain, Hyperhidrosis, Nail Disorder, Dry Mouth, Vertigo, Abdominal Pain Upper, Asthenia
This Alopecia Totalis, Anti-thyroid Antibody, Chest Pain, Hyperhidrosis, Nail Disorder, Dry Mouth, Vertigo, Abdominal Pain Upper, Asthenia problem was reported by a consumer or non-health professional from FR. A 55-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: glaucoma,ulcerative keratitis. On 201304 this consumer started treatment with Carteol Lp 2% Collyre A Liberation Prolongee (dosage: NA). The following drugs were being taken at the same time:
  • Tobrex
  • Euronac
When commencing Carteol Lp 2% Collyre A Liberation Prolongee, the patient experienced the following unwanted symptoms/side effects:
  • Alopecia Totalis
  • Anti-thyroid Antibody
  • Chest Pain
  • Hyperhidrosis
  • Nail Disorder
  • Dry Mouth
  • Vertigo
  • Abdominal Pain Upper
  • Asthenia
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as alopecia totalis, may become evident only after a product is in use by the general population.

Completed Suicide, Depression, Night Sweats, Insomnia, Visual Acuity Reduced
This is a report of a 78-year-old female patient (weight: NA) from FR. The patient developed the following symptoms/conditions: NA and was treated with Carteol Lp 2% Collyre A Liberation Prolongee (dosage: NA) starting Dec 14, 2012. Concurrently used drugs:
  • Mianserine Almus
  • Temesta
  • Ixprim (37.5/325 Mg)
  • Olmetec
  • Vastarel
  • Actonel
  • Topalgic Lp
  • Cortancyl
Soon after that, the consumer experienced the following side effects:
  • Completed Suicide
  • Depression
  • Night Sweats
  • Insomnia
  • Visual Acuity Reduced
This opens a possibility that Carteol Lp 2% Collyre A Liberation Prolongee treatment could cause the above reactions, including completed suicide, and some female subjects may be more susceptible.


Asphyxia
A 76-year-old female patient (weight: NA) from FR with the following symptoms/conditions: glaucoma started Carteol treatment (dosage: NA) on May 27, 2013. Soon after starting Carteol treatment, the subject experienced various side effects, including:
  • Asphyxia
Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Carteol.

Dark Circles Under Eyes, Eye Pruritus
A 71-year-old female patient from US (weight: NA) experienced symptoms, such as: NA and was treated with Carteolol Hydrochloride(dosage: 1 Drop In Each Eye Daily). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
  • Dark Circles Under Eyes
  • Eye Pruritus
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Carteolol Hydrochloride efficacy:
  • Latanoprost
  • Travoprost


Hypertrophic Cardiomyopathy
In this report, Carteol 1% Collyre was administered for the following condition: NA.A 71-year-old female consumer from FR (weight: NA) started Carteol 1% Collyre treatment (dosage: NA) on NS.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Hypertrophic Cardiomyopathy
A possible interaction with other drugs could have contributed to this reaction:
  • Kivexa
  • Aldactone
  • Lucentis 10 Mg/ml, Solution Injectable
  • Sustiva
  • Travatan
  • Mono-tildiem
  • Crestor 5 Mg
Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Carteol 1% Collyre treatment could be related to the listed above side effect(s).

Caesarean Section, Visual Field Defect, Cervix Disorder, Premature Labour, Normal Newborn, Maternal Exposure During Pregnancy
This is a report of the following Carteol Lp 1% Collyre En Solution En Recipient Unidose side effect(s):
  • Caesarean Section
  • Visual Field Defect
  • Cervix Disorder
  • Premature Labour
  • Normal Newborn
  • Maternal Exposure During Pregnancy
A 28-year-old female patient from FRANCE (weight: NA) presented with the following condition: glaucoma and received a treatment with Carteol Lp 1% Collyre En Solution En Recipient Unidose (dosage: NA) starting: Jan 01, 2003.The following concurrently used drugs could have generated interactions: NA.This report suggests that a Carteol Lp 1% Collyre En Solution En Recipient Unidose treatment could be associated with the listed above side effect(s).

Foetal Distress Syndrome
This Carteolol Hydrochloride report was submitted by a male consumer from FRANCE (weight: NA). The patient was diagnosed with: glaucoma and Carteolol Hydrochloride was administered (dosage: Unk) starting: Apr 10, 2010. The consumer developed a set of symptoms:
  • Foetal Distress Syndrome
Other drugs used simultaneously:
  • Xalatan (1 Df, 1x/day)
Those unexpected symptoms could be linked to a Carteolol Hydrochloride treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Loss Of Consciousness, Cardiac Disorder, Fall
This is a report of a possible correlation between Carteolol Hydrochloride use and the following symptoms/side effect(s):
  • Loss Of Consciousness
  • Cardiac Disorder
  • Fall
which could contribute to an assessment of Carteolol Hydrochloride risk profile.A 91-year-old male consumer from JAPAN (weight: NA) was suffering from NA and was treated with Carteolol Hydrochloride (dosage: Unk Ukn, Unk) starting NS.Other concurrent medications:
  • Xalatan (Unk Ukn, Unk)


Intraocular Pressure Increased, Therapeutic Response Decreased, Conjunctival Hyperaemia
A 77-year-old female patient from JAPAN (weight: NA) presented with the following symptoms: NA and after a treatment with Carteolol Hydrochloride (dosage: Unk) experienced the following side effect(s):
  • Intraocular Pressure Increased
  • Therapeutic Response Decreased
  • Conjunctival Hyperaemia
The treatment was started on Oct 12, 2010. Carteolol Hydrochloride was used in combination with the following drugs:
  • Lumigan (1 Gtt, Qd)
  • Mikelan La (Unk)
  • Trusopt
  • Detantol (Unk)
  • Fluorometholone
  • Diamox Src (Unk)
  • Aspara K (Unk)
This report could alert potential Carteolol Hydrochloride consumers.

Visual Field Defect, Punctate Keratitis, Conjunctival Hyperaemia
In this report, a 65-year-old female patient from JAPAN (weight: NA) was affected by a possible Carteolol Hydrochloride side effect.The patient was diagnosed with NA. After a treatment with Carteolol Hydrochloride (dosage: Unk, start date: Mar 08, 2010), the patient experienced the following side effect(s):
  • Visual Field Defect
  • Punctate Keratitis
  • Conjunctival Hyperaemia
The following simultaneously used drugs could have led to this reaction:
  • Azopt (Unk)
  • Lumigan (1 Gtt, Night Time)
The findings here stress that side effects should be taken into consideration when evaluating a Carteolol Hydrochloride treatment.

Intraocular Pressure Increased
This is a report of a 80-year-old female patient from JAPAN (weight: NA), who used Carteolol Hydrochloride (dosage: Unk) for a treatment of NA. After starting a treatment on Oct 23, 2008, the patient experienced the following side effect(s):
  • Intraocular Pressure Increased
The following drugs could possibly have interacted with the Carteolol Hydrochloride treatment
  • Lumigan (2 Gtt, Qd)
  • Livostin (Unk)
  • Trusopt (Unk)
The patient was hospitalized.Taken together, these observations suggest that a Carteolol Hydrochloride treatment could be related to side effect(s), such as Intraocular Pressure Increased.

Retinal Vascular Disorder, Visual Acuity Reduced
This retinal vascular disorder side effect was reported by a consumer or non-health professional from JAPAN. A 82-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Carteolol Hydrochloride (dosage: Unk), which was started on Apr 14, 2010. Concurrently used drugs:
  • Lumigan (1 Gtt, Qpm)
  • Tafluprost (Unk)
  • Levofloxacin (Unk)
  • Rinderon-a (Unk)
When starting to take Carteolol Hydrochloride the consumer reported the following symptoms:
  • Retinal Vascular Disorder
  • Visual Acuity Reduced
These side effects may potentially be related to Carteolol Hydrochloride.

X-ray Abnormal, Sepsis, Ileus, Intestinal Perforation, Abdominal Pain
This is a Carteolol Hydrochloride side effect report of a 63-year-old female patient (weight:NA) from JAPAN, suffering from the following symptoms/conditions: tachycardia,blood pressure decreased,hyperphosphataemia,hyperuricaemia,osteoporosis,gastric ulcer, who was treated with Carteolol Hydrochloride (dosage:NA, start time: Nov 30, 2009), combined with: NA., and developed a serious reaction and a x-ray abnormal side effect. The patient presented with:
  • X-ray Abnormal
  • Sepsis
  • Ileus
  • Intestinal Perforation
  • Abdominal Pain
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Carteolol Hydrochloride treatment in female patients suffering from tachycardia,blood pressure decreased,hyperphosphataemia,hyperuricaemia,osteoporosis,gastric ulcer, resulting in x-ray abnormal.

Syncope, Dizziness, Pneumonia
This report suggests a potential Carteolol Hydrochloride syncope side effect(s) that can have serious consequences. A 46-year-old female patient from JAPAN (weight:NA) was diagnosed with the following health condition(s): glaucoma and used Carteolol Hydrochloride (dosage: Unk Ukn, Unk) starting NS. Soon after starting Carteolol Hydrochloride the patient began experiencing various side effects, including:
  • Syncope
  • Dizziness
  • Pneumonia
Drugs used concurrently:
  • Tafluprost (Unk Ukn, Unk)
The patient was hospitalized. Although Carteolol Hydrochloride demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as syncope, may still occur.

Blood Pressure Systolic Increased, Nocturia, Hypertensive Encephalopathy, Discomfort
This blood pressure systolic increased problem was reported by a physician from JAPAN. A 72-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): NA.On Apr 28, 2011 a consumer started treatment with Carteolol Hydrochloride (dosage: 15 Mg, Unk). The following drugs/medications were being taken at the same time:
  • Bezatol (400 Mg, Unk)
  • Ticlopidine Hcl (100 Mg, Unk)
  • Irbesartan (100 Mg, Unk)
  • Avapro (50 Mg, Unk)
  • Diazepam
  • Depas
  • Amoban (7.5 Mg, Unk)
  • Plavix (75 Mg, Unk)
When commencing Carteolol Hydrochloride, the patient experienced the following unwanted symptoms /side effects:
  • Blood Pressure Systolic Increased
  • Nocturia
  • Hypertensive Encephalopathy
  • Discomfort
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as blood pressure systolic increased, may become evident only after a product is in use by the general population.

Pyrexia, Asthenia, Malaise, Hypophagia, International Normalised Ratio Increased, Bone Pain, Haematuria, Dry Mouth, Anaemia
This is a Carteolol Hydrochloride side effect report of a 90-year-old male patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: NA and was treated with Carteolol Hydrochloride (dosage: Unk Unk, Bid) starting Mar 11, 2011. Concurrently used drugs:
  • Xgeva (120 Mg, Q4wk)
  • Simvastatin (20 Mg, Qd)
  • Vitamin B12 /00056201/
  • Vitamin B6
  • Folic Acid
  • Coumadin
  • Bicalutamide (50 Mg, Qd)
  • Sotalol Hcl (320 Mg, Qd)
Soon after that, the consumer experienced the following of symptoms:
  • Pyrexia
  • Asthenia
  • Malaise
  • Hypophagia
  • International Normalised Ratio Increased
  • Bone Pain
  • Haematuria
  • Dry Mouth
  • Anaemia
The patient was hospitalized. This opens a possibility that Carteolol Hydrochloride could cause pyrexia and that some male patients may be more susceptible.

Tendonitis
A 71-year-old male patient (weight: NA) from FRANCE with the following symptoms: NA started Carteolol Hydrochloride treatment (dosage: NA) on Oct 01, 2006. Soon after starting Carteolol Hydrochloride treatment, the consumer experienced several side effects, including:
  • Tendonitis
. Concurrently used drugs:
  • Isradipine
  • Zetia
  • Aspirin Lysine
This finding indicates that some patients can be more vulnerable to developing Carteolol Hydrochloride side effects, such as tendonitis.

Tendonitis
This tendonitis side effect was reported by a health professional from FRANCE. A 71-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Carteolol Hydrochloride (dosage: NA), which was started on Jan 01, 2007. Concurrently used drugs:
  • Aspirin Lysine
  • Isradipine
  • Zetia
.When starting to take Carteolol Hydrochloride the consumer reported symptoms, such as:
  • Tendonitis
These side effects may potentially be related to Carteolol Hydrochloride.

Dermatitis Bullous, Oropharyngeal Blistering, Pemphigus
This is a report of a 67-year-old female patient (weight: NA) from FRANCE, suffering from the following symptoms/conditions: intraocular pressure increased, who was treated with Carteol Lp 2% Collyre En Sol Recipient Unidose (dosage: NA, start time: Jan 01, 2000), combined with:
  • Pravastatin
and developed a serious reaction and side effect(s). The consumer presented with:
  • Dermatitis Bullous
  • Oropharyngeal Blistering
  • Pemphigus
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Carteol Lp 2% Collyre En Sol Recipient Unidose treatment in female patients, resulting in dermatitis bullous side effect. The patient was hospitalized.

Dermatitis Bullous, Oropharyngeal Blistering
This report suggests a potential Carteolol Hydrochloride Dermatitis Bullous, Oropharyngeal Blistering side effect(s) that can have serious consequences. A 67-year-old female patient (weight: NA) from JAPAN was diagnosed with the following symptoms/conditions: intraocular pressure increased and used Carteolol Hydrochloride (dosage: 1 Gtt, Qd) starting May 21, 2010. Soon after starting Carteolol Hydrochloride the patient began experiencing various side effects, including:
  • Dermatitis Bullous
  • Oropharyngeal Blistering
Drugs used concurrently:
  • Pravastatin (Unk)
Although Carteolol Hydrochloride demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as dermatitis bullous, may still occur.

Arthritis, Joint Swelling, Rheumatoid Arthritis, Spondylitis
This Arthritis, Joint Swelling, Rheumatoid Arthritis, Spondylitis problem was reported by a physician from FRANCE. A 57-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: ocular hypertension. On Jan 01, 2010 this consumer started treatment with Carteol Lp 2% Collyre En Solution A Liberation Prolongee (dosage: NA). The following drugs were being taken at the same time:
  • Xalatan /swe/
When commencing Carteol Lp 2% Collyre En Solution A Liberation Prolongee, the patient experienced the following unwanted symptoms/side effects:
  • Arthritis
  • Joint Swelling
  • Rheumatoid Arthritis
  • Spondylitis
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as arthritis, may become evident only after a product is in use by the general population.

Dermatitis Bullous, Oropharyngeal Blistering, Pemphigus
This is a report of a 67-year-old female patient (weight: NA) from FRANCE. The patient developed the following symptoms/conditions: intraocular pressure increased and was treated with Carteol Lp 2% Collyre En Sol Recipient Unidose (dosage: NA) starting Jan 01, 2000. Concurrently used drugs:
  • Pravastatin
Soon after that, the consumer experienced the following side effects:
  • Dermatitis Bullous
  • Oropharyngeal Blistering
  • Pemphigus
The patient was hospitalized. This opens a possibility that Carteol Lp 2% Collyre En Sol Recipient Unidose treatment could cause the above reactions, including dermatitis bullous, and some female subjects may be more susceptible.

Arthritis, Joint Swelling, Rheumatoid Arthritis, Spondylitis
A 57-year-old female patient (weight: NA) from FRANCE with the following symptoms/conditions: ocular hypertension started Carteol Lp 2% Collyre En Solution A Liberation Prolongee treatment (dosage: NA) on Jan 01, 2010. Soon after starting Carteol Lp 2% Collyre En Solution A Liberation Prolongee treatment, the subject experienced various side effects, including:
  • Arthritis
  • Joint Swelling
  • Rheumatoid Arthritis
  • Spondylitis
Concurrently used drugs:
  • Xalatan /swe/
This finding indicates that some female patients could be more vulnerable to Carteol Lp 2% Collyre En Solution A Liberation Prolongee.

1 of 3 

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Carteol Side Effects

    Did You Have a Carteol Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Carteol for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Carteol Safety Alerts, Active Ingredients, Usage Information

    NDC24208-367
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameCARTEOLOL HYDROCHLORIDE
    NameCARTEOLOL HYDROCHLORIDE
    Dosage FormSOLUTION/ DROPS
    RouteOPHTHALMIC
    On market since20000120
    LabelerBausch & Lomb Incorporated
    Active Ingredient(s)CARTEOLOL HYDROCHLORIDE
    Strength(s)10
    Unit(s)mg/mL
    Pharma ClassAdrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]

    More About Carteol

    Side Effects reported to FDA: 62

    Carteol safety alerts: No

    Reported deaths: 1

    Reported hospitalizations: 16

    Latest Carteol clinical trials

    Carteol Reviews

    No reviews, be a first to report a side effect via side effect reporting form